Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome

J. Burn, D.T. Bishop, J.P. Mecklin, F. Macrae, G. Moslein, S. Olschwang, M.L. Bisgaard, R. Ramesar, D. Eccles, E.R. Maher, L. Bertario, H.J. Jarvinen, A. Lindblom, D.G. Evans, J. Lubinski, Patrick Morrison, J.W.C. Ho, H.F.A. Vasen, L. Side, H.J.W. ThomasR.J. Scott, M. Dunlop, G. Barker, F. Elliott, J.R. Jass, R. Fodde, H.T. Lynch, J.C. Mathers

Research output: Contribution to journalArticlepeer-review

216 Citations (Scopus)

Abstract

Background: Observational and epidemiologic data indicate that the use of aspirin reduces the risk of colorectal neoplasia; however, the effects of aspirin in the Lynch syndrome (hereditary nonpolyposis colon cancer) are not known. Resistant starch has been associated with an antineoplastic effect on the colon.
Original languageEnglish
Pages (from-to)2567-2578
Number of pages12
JournalNew England Journal of Medicine
Volume359
Issue number24
Publication statusPublished - 11 Dec 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome'. Together they form a unique fingerprint.

Cite this